--- title: "Phio Pharmaceuticals director Ronald Todd Plott files initial beneficial ownership statement" type: "News" locale: "en" url: "https://longbridge.com/en/news/294407858.md" description: "Phio Pharmaceuticals filed a Form 3 with the SEC on July 20, 2026, designating Ronald Todd Plott as a director. This filing serves as an initial beneficial ownership statement for Mr. Plott." datetime: "2026-07-30T20:02:09.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294407858.md) - [en](https://longbridge.com/en/news/294407858.md) - [zh-HK](https://longbridge.com/zh-HK/news/294407858.md) generator: "portal-rs" --- # Phio Pharmaceuticals director Ronald Todd Plott files initial beneficial ownership statement - Phio Pharmaceuticals filed a Form 3 naming Ronald Todd Plott as a director on July 20, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-005842), on July 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here ### Related Stocks - [PHIO.US](https://longbridge.com/en/quote/PHIO.US.md) ## Related News & Research - [Phio Pharmaceuticals CEO Robert J. Bitterman reports purchase of $10,600 in common shares](https://longbridge.com/en/news/296394316.md) - [Top Executive Makes Bold Insider Move at Biotech Firm](https://longbridge.com/en/news/296434198.md) - [Baosheng Media files Form 3 initial beneficial ownership statement for CEO, director Lina Jiang](https://longbridge.com/en/news/296507606.md) - [YSX Tech files Form 3 initial beneficial ownership statement for director Wu Jifeng](https://longbridge.com/en/news/296394699.md) - [Solventum files Form 3 for SVP, Controller and CAO Neil Zieselman](https://longbridge.com/en/news/296265352.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**